Cargando…

Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age

OBJECTIVE: The prognostic role of age among patients affected by Oral Tongue Squamous Cell Carcinoma (OTSCC) is a topic of debate. Recent cohort studies have found that patients diagnosed at 40 years of age or younger have a better prognosis. The aim of this cohort study was to clarify whether age i...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansarin, Mohssen, De Berardinis, Rita, Corso, Federica, Giugliano, Gioacchino, Bruschini, Roberto, De Benedetto, Luigi, Zorzi, Stefano, Maffini, Fausto, Sovardi, Fabio, Pigni, Carolina, Scaglione, Donatella, Alterio, Daniela, Cossu Rocca, Maria, Chiocca, Susanna, Gandini, Sara, Tagliabue, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075362/
https://www.ncbi.nlm.nih.gov/pubmed/33912446
http://dx.doi.org/10.3389/fonc.2021.616653
_version_ 1783684526874034176
author Ansarin, Mohssen
De Berardinis, Rita
Corso, Federica
Giugliano, Gioacchino
Bruschini, Roberto
De Benedetto, Luigi
Zorzi, Stefano
Maffini, Fausto
Sovardi, Fabio
Pigni, Carolina
Scaglione, Donatella
Alterio, Daniela
Cossu Rocca, Maria
Chiocca, Susanna
Gandini, Sara
Tagliabue, Marta
author_facet Ansarin, Mohssen
De Berardinis, Rita
Corso, Federica
Giugliano, Gioacchino
Bruschini, Roberto
De Benedetto, Luigi
Zorzi, Stefano
Maffini, Fausto
Sovardi, Fabio
Pigni, Carolina
Scaglione, Donatella
Alterio, Daniela
Cossu Rocca, Maria
Chiocca, Susanna
Gandini, Sara
Tagliabue, Marta
author_sort Ansarin, Mohssen
collection PubMed
description OBJECTIVE: The prognostic role of age among patients affected by Oral Tongue Squamous Cell Carcinoma (OTSCC) is a topic of debate. Recent cohort studies have found that patients diagnosed at 40 years of age or younger have a better prognosis. The aim of this cohort study was to clarify whether age is an independent prognostic factor and discuss heterogeneity of outcomes by stage and treatments in different age groups. METHODS: We performed a study on 577 consecutive patients affected by primary tongue cancer and treated with surgery and adjuvant therapy according to stage, at European Institute of Oncology, IRCCS. Patients with age at diagnosis below 40 years totaled 109 (19%). Overall survival (OS), disease-free survival (DFS), tongue specific free survival (TSFS) and cause-specific survival (CSS) were compared by age groups. Multivariate Cox proportional hazards models were used to assess the independent role of age. RESULTS: The median follow-up time was 5.01 years (range 0–18.68) years with follow-up recorded up to February 2020. After adjustment for all the significant confounding and prognostic factors, age remained independently associated with OS and DSF (respectively, p = 0.002 and p = 0.02). In CSS and TSFS curves, the role of age seems less evident (respectively, p = 0.14 and p = 0.0.37). In the advanced stage sub-group (stages III–IV), age was significantly associated with OS and CSS with almost double increased risk of dying (OS) and dying from tongue cancer (CSS) in elderly compared to younger groups (OS: HR = 2.16 95%, CI: 1.33–3.51, p= 0.001; CSS: HR = 1.76 95%, CI: 1.03–3.01, p = 0.02, respectively). In our study, young patients were more likely to be treated with intensified therapies (glossectomies types III–V and adjuvant radio-chemotherapy). Age was found as a prognostic factor, independently of other significant factors and treatment. Also the T–N tract involved by disease and neutrophil-to-lymphocyte ratio ≥3 were independent prognostic factors. CONCLUSIONS: Young age at diagnosis is associated with a better overall survival. Fewer younger people than older people died from tongue cancer in advanced stages.
format Online
Article
Text
id pubmed-8075362
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80753622021-04-27 Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age Ansarin, Mohssen De Berardinis, Rita Corso, Federica Giugliano, Gioacchino Bruschini, Roberto De Benedetto, Luigi Zorzi, Stefano Maffini, Fausto Sovardi, Fabio Pigni, Carolina Scaglione, Donatella Alterio, Daniela Cossu Rocca, Maria Chiocca, Susanna Gandini, Sara Tagliabue, Marta Front Oncol Oncology OBJECTIVE: The prognostic role of age among patients affected by Oral Tongue Squamous Cell Carcinoma (OTSCC) is a topic of debate. Recent cohort studies have found that patients diagnosed at 40 years of age or younger have a better prognosis. The aim of this cohort study was to clarify whether age is an independent prognostic factor and discuss heterogeneity of outcomes by stage and treatments in different age groups. METHODS: We performed a study on 577 consecutive patients affected by primary tongue cancer and treated with surgery and adjuvant therapy according to stage, at European Institute of Oncology, IRCCS. Patients with age at diagnosis below 40 years totaled 109 (19%). Overall survival (OS), disease-free survival (DFS), tongue specific free survival (TSFS) and cause-specific survival (CSS) were compared by age groups. Multivariate Cox proportional hazards models were used to assess the independent role of age. RESULTS: The median follow-up time was 5.01 years (range 0–18.68) years with follow-up recorded up to February 2020. After adjustment for all the significant confounding and prognostic factors, age remained independently associated with OS and DSF (respectively, p = 0.002 and p = 0.02). In CSS and TSFS curves, the role of age seems less evident (respectively, p = 0.14 and p = 0.0.37). In the advanced stage sub-group (stages III–IV), age was significantly associated with OS and CSS with almost double increased risk of dying (OS) and dying from tongue cancer (CSS) in elderly compared to younger groups (OS: HR = 2.16 95%, CI: 1.33–3.51, p= 0.001; CSS: HR = 1.76 95%, CI: 1.03–3.01, p = 0.02, respectively). In our study, young patients were more likely to be treated with intensified therapies (glossectomies types III–V and adjuvant radio-chemotherapy). Age was found as a prognostic factor, independently of other significant factors and treatment. Also the T–N tract involved by disease and neutrophil-to-lymphocyte ratio ≥3 were independent prognostic factors. CONCLUSIONS: Young age at diagnosis is associated with a better overall survival. Fewer younger people than older people died from tongue cancer in advanced stages. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8075362/ /pubmed/33912446 http://dx.doi.org/10.3389/fonc.2021.616653 Text en Copyright © 2021 Ansarin, De Berardinis, Corso, Giugliano, Bruschini, De Benedetto, Zorzi, Maffini, Sovardi, Pigni, Scaglione, Alterio, Cossu Rocca, Chiocca, Gandini and Tagliabue https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ansarin, Mohssen
De Berardinis, Rita
Corso, Federica
Giugliano, Gioacchino
Bruschini, Roberto
De Benedetto, Luigi
Zorzi, Stefano
Maffini, Fausto
Sovardi, Fabio
Pigni, Carolina
Scaglione, Donatella
Alterio, Daniela
Cossu Rocca, Maria
Chiocca, Susanna
Gandini, Sara
Tagliabue, Marta
Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age
title Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age
title_full Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age
title_fullStr Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age
title_full_unstemmed Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age
title_short Survival Outcomes in Oral Tongue Cancer: A Mono-Institutional Experience Focusing on Age
title_sort survival outcomes in oral tongue cancer: a mono-institutional experience focusing on age
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075362/
https://www.ncbi.nlm.nih.gov/pubmed/33912446
http://dx.doi.org/10.3389/fonc.2021.616653
work_keys_str_mv AT ansarinmohssen survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT deberardinisrita survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT corsofederica survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT giuglianogioacchino survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT bruschiniroberto survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT debenedettoluigi survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT zorzistefano survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT maffinifausto survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT sovardifabio survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT pignicarolina survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT scaglionedonatella survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT alteriodaniela survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT cossuroccamaria survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT chioccasusanna survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT gandinisara survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage
AT tagliabuemarta survivaloutcomesinoraltonguecanceramonoinstitutionalexperiencefocusingonage